Abubakar, I;
Lipman, M;
McHugh, TD;
Fletcher, H;
(2016)
Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatment.
BMC Medicine
, 14
, Article 47. 10.1186/s12916-016-0599-1.
Preview |
Text
Lipman_Uniting to end the TB epidemic%3A advances in disease control from prevention to better diagnosis and treatment.pdf Download (1MB) | Preview |
Abstract
Tuberculosis is a major global cause of morbidity and mortality. Despite recent advances in containing the epidemic, several challenges continue to slow progress towards elimination including the continuing impact of drug resistant disease, and the lack of appropriate tools. Curtailing the transmission of tuberculosis remains a challenge especially in high burden countries. New developments in measuring correlates of protection are urgently needed to support the evaluation of vaccines. Similarly, despite progress in molecular diagnostics, better tools are required to identify resistance to antibiotics in multi and extensively drug resistant tuberculosis. Whole Genome Sequencing may lead to the next generation of assays to rapidly detect resistance and evaluate transmission. Advances on shortening treatment are hampered by the lack of a biomarker of cure which obviates the current long wait for relapses in trials. New research is urgently needed to support development of new vaccines and better diagnostics tools and shorter treatment for drug sensitive and resistant tuberculosis.
Type: | Article |
---|---|
Title: | Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatment |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1186/s12916-016-0599-1 |
Publisher version: | http://dx.doi.org/10.1186/s12916-016-0599-1 |
Language: | English |
Additional information: | Copyright © Abubakar et al. 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
Keywords: | Elimination, Multi-drug resistant tuberculosis, Tuberculosis |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine |
URI: | https://discovery.ucl.ac.uk/id/eprint/1481238 |




Archive Staff Only
![]() |
View Item |